NEJM - An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

NEJM - An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

The New England Journal of MedicineThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine...
NEJM - Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models

NEJM - Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models

The New England Journal of MedicineThe third coronavirus outbreak in the past 20 years, the SARS-CoV-2 pandemic has caused unprecedented morbidity, mortality, and economic disruption. Safe, effective, and deployable SARS-CoV-2 vaccines are...
NEJM - Developing Covid-19 Vaccines at Pandemic Speed

NEJM - Developing Covid-19 Vaccines at Pandemic Speed

The New England Journal of MedicineThe need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era...
WHO - Bacille Calmette-Guérin (BCG) vaccination and COVID-19

WHO - Bacille Calmette-Guérin (BCG) vaccination and COVID-19

World Health OrganizationThere is no evidence that the Bacille Calmette-Guérin vaccine (BCG) protects people against infection with COVID-19 virus. Two clinical trials addressing this question are underway, and WHO will evaluate the evidence when...
1234
Eventos
«junho de 2023»
segterquaquisexsábdom
2930311234
567891011
12131415161718
19202122232425
262728293012
3456789
Categorias

Categorias

Arquivo de Notícias

Arquivo